Results 241 to 250 of about 689,735 (295)
Unfolding Hidden Narratives: Glimpses of an Ethos of Senses in a Dementia-Care Facility. [PDF]
van Wijngaarden E.
europepmc +1 more source
Objective Vacuoles E1 enzyme X‐linked autoinflammatory somatic syndrome (VEXAS) is a recently identified rare genetic disorder associated with somatic mutations in the UBA1 gene. VEXAS presents with a combination of inflammatory and hematologic manifestations, leading to increased morbidity and mortality.
Arsene Mekinian +111 more
wiley +1 more source
Framework for charged compact objects admitting conformal motion in higher dimension. [PDF]
Zahra A, Mardan SA, Riaz MB, Manzoor R.
europepmc +1 more source
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane +33 more
wiley +1 more source
Living with congenital heart disease: a qualitative study to explore psychosocial impacts in adulthood. [PDF]
Lloyd L +5 more
europepmc +1 more source
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama +16 more
wiley +1 more source
Guest Editorial: Structure and mechanics of biofluids, biomaterials, and biologics. [PDF]
Furst EM, Scheffold F, McKinley GH.
europepmc +1 more source
Strange quark matter as dark matter: 40 yr later, a reappraisal [PDF]
Francesco Di Clemente +4 more
openalex +1 more source
Objectives The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's Phenomenon (RP) and to explore their potential pathophysiological mechanisms through a mixed disproportionality/clustering analysis from the WHO pharmacovigilance database.
Alex Hlavaty +4 more
wiley +1 more source

